| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | METHOTREXATE | 4 |
| 2 | METHOTREXATE SODIUM | 4 |
| 3 | CLOZAPINE | 3 |
| 4 | FLUOXETINE HYDROCHLORIDE | 3 |
| 5 | PAROXETINE HYDROCHLORIDE | 3 |
| 6 | PREDNISOLONE | 3 |
| 7 | PREDNISOLONE ORAL | 3 |
| 8 | PREDNISOLONE ORAL SOLUTION | 3 |
| 9 | QUETIAPINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALIFERMIN | 1 | 0.0026 |
| 1 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 2 | FLUCYTOSINE | 1 | 0.0007 |
| 3 | NITRIC OXIDE | 1 | 0.0002 |
| 4 | AMISULPRIDE | 1 | 0.0002 |
| 5 | PHYTONADIONE | 1 | 0.0001 |
| 6 | ASENAPINE MALEATE | 1 | 0.0001 |
| 7 | GLECAPREVIR AND PIBRENTASVIR | 1 | 0.0001 |
| 8 | PAROXETINE HYDROCHLORIDE | 3 | 0.0001 |
| 9 | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Vitamin K [EPC] | 1 | 0.0001 |
| 4 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |